Anasayfa
Haberler
Tercüme
Proje
Forum
Yardım
Uyeler
Login
Kayıt Ol
. .
•Profil
ervintoth
•Tüm çeviriler
▪▪Talep edilen çeviriler
•
Favori tercümeler
•Projelerin listesi
•Gelenler
▪Bedava dil deÄŸiÅŸ tokuÅŸu
•English
▪▪Türkçe
•Français
•Español
•Italiano
•Português brasileiro
•Deutsch
•Română
•عربي
•Русский
•Svenska
•Ελληνικά
•Български
•עברית
•Shqip
•Srpski
•Nederlands
•Dansk
•Português
•Polski
•汉语(简体)
•Lietuvių
•Norsk
•فارسی
•Suomi
•Hrvatski
•日本語
•Català
•Esperanto
•한국어
•Українська
•Føroyskt
•नेपाली
•Kiswahili
Tüm çeviriler
Arama
Talep edilen çeviriler - ervintoth
Arama
Kaynak dil
Hedef dil
2 sonuçtan 1 - 2 arası sonuçlar
1
384
Kaynak dil
ASSESSMENT OF SMALL BOWEL SAFETY OF LUMIRACOXIB 100 MG OD
Of 152 randomized subjects, 139 completed the study with valid VCEs. Compared with placebo, an increased number of subjects on naproxen plus omeprazole had small bowel mucosal breaks , with increased permeability and raised faecal calprotectin . .There was no increase in permeability. As assessed by three different measures, acute small bowel injury on lumiracoxib treatment is less frequent than with naproxen plus omeprazole and similar to placebo.
Tamamlanan çeviriler
Uppskattning av lumiracoxibs 100 mg od tunntarmssäkerhet
1